These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32644062)

  • 1. Up-regulation of neprilysin mediates the protection of fructo-oligosaccharides against Alzheimer's disease.
    Wu S; Zhang J; Jiang C; Wang S; Que R; An L
    Food Funct; 2020 Jul; 11(7):6565-6572. PubMed ID: 32644062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neprilysin deficiency alters the neuropathological and behavioral phenotype in the 5XFAD mouse model of Alzheimer's disease.
    Hüttenrauch M; Baches S; Gerth J; Bayer TA; Weggen S; Wirths O
    J Alzheimers Dis; 2015; 44(4):1291-302. PubMed ID: 25408216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-HIAA induces neprilysin to ameliorate pathophysiology and symptoms in a mouse model for Alzheimer's disease.
    Klein C; Roussel G; Brun S; Rusu C; Patte-Mensah C; Maitre M; Mensah-Nyagan AG
    Acta Neuropathol Commun; 2018 Dec; 6(1):136. PubMed ID: 30537985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of trichostatin A on gelsolin levels, proteolysis of amyloid precursor protein, and amyloid beta-protein load in the brain of transgenic mouse model of Alzheimer's disease.
    Yang W; Chauhan A; Wegiel J; Kuchna I; Gu F; Chauhan V
    Curr Alzheimer Res; 2014; 11(10):1002-11. PubMed ID: 25387339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. γ-Hydroxybutyrate (Xyrem) ameliorates clinical symptoms and neuropathology in a mouse model of Alzheimer's disease.
    Klein C; Mathis C; Leva G; Patte-Mensah C; Cassel JC; Maitre M; Mensah-Nyagan AG
    Neurobiol Aging; 2015 Feb; 36(2):832-44. PubMed ID: 25457559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant soluble neprilysin reduces amyloid-beta accumulation and improves memory impairment in Alzheimer's disease mice.
    Park MH; Lee JK; Choi S; Ahn J; Jin HK; Park JS; Bae JS
    Brain Res; 2013 Sep; 1529():113-24. PubMed ID: 23831521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A combination Alzheimer's therapy targeting BACE1 and neprilysin in 5XFAD transgenic mice.
    Devi L; Ohno M
    Mol Brain; 2015 Mar; 8():19. PubMed ID: 25884928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripherally expressed neprilysin reduces brain amyloid burden: a novel approach for treating Alzheimer's disease.
    Guan H; Liu Y; Daily A; Police S; Kim MH; Oddo S; LaFerla FM; Pauly JR; Murphy MP; Hersh LB
    J Neurosci Res; 2009 May; 87(6):1462-73. PubMed ID: 19021293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood-brain barrier penetrating neprilysin degrades monomeric amyloid-beta in a mouse model of Alzheimer's disease.
    Rofo F; Metzendorf NG; Saubi C; Suominen L; Godec A; Sehlin D; Syvänen S; Hultqvist G
    Alzheimers Res Ther; 2022 Dec; 14(1):180. PubMed ID: 36471433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (-)-Epigallocatechin-3-gallate attenuates cognitive deterioration in Alzheimer's disease model mice by upregulating neprilysin expression.
    Chang X; Rong C; Chen Y; Yang C; Hu Q; Mo Y; Zhang C; Gu X; Zhang L; He W; Cheng S; Hou X; Su R; Liu S; Dun W; Wang Q; Fang S
    Exp Cell Res; 2015 May; 334(1):136-45. PubMed ID: 25882496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Insulin Degrading Enzyme and Neprilysin in Alzheimer's Disease Biology: Characterization of Putative Cognates for Therapeutic Applications.
    Jha NK; Jha SK; Kumar D; Kejriwal N; Sharma R; Ambasta RK; Kumar P
    J Alzheimers Dis; 2015; 48(4):891-917. PubMed ID: 26444774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding molecular mechanisms of proteolysis in Alzheimer's disease: progress toward therapeutic interventions.
    Higuchi M; Iwata N; Saido TC
    Biochim Biophys Acta; 2005 Aug; 1751(1):60-7. PubMed ID: 16054018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aβ-degrading enzymes: potential for treatment of Alzheimer disease.
    Miners JS; Barua N; Kehoe PG; Gill S; Love S
    J Neuropathol Exp Neurol; 2011 Nov; 70(11):944-59. PubMed ID: 22002425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neprilysin inhibitors and risk of Alzheimer's disease: A future perspective.
    Ali NH; Al-Kuraishy HM; Al-Gareeb AI; Alnaaim SA; Alexiou A; Papadakis M; Khalifa AA; Saad HM; Batiha GE
    J Cell Mol Med; 2024 Jan; 28(2):e17993. PubMed ID: 37847125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Elucidating Pathogenic Mechanisms of Early-onset Alzheimer's Disease in Down Syndrome Patients].
    Asai M; Kawakubo T; Mori R; Iwata N
    Yakugaku Zasshi; 2017; 137(7):801-805. PubMed ID: 28674290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neprilysin: an enzyme candidate to slow the progression of Alzheimer's disease.
    El-Amouri SS; Zhu H; Yu J; Marr R; Verma IM; Kindy MS
    Am J Pathol; 2008 May; 172(5):1342-54. PubMed ID: 18403590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neprilysin-2 is an important β-amyloid degrading enzyme.
    Hafez D; Huang JY; Huynh AM; Valtierra S; Rockenstein E; Bruno AM; Lu B; DesGroseillers L; Masliah E; Marr RA
    Am J Pathol; 2011 Jan; 178(1):306-12. PubMed ID: 21224067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neprilysin degrades murine Amyloid-β (Aβ) more efficiently than human Aβ: Further implication for species-specific amyloid accumulation.
    Becker M; Moore A; Naughton M; Boland B; Siems WE; Walther T
    Neurosci Lett; 2018 Nov; 686():74-79. PubMed ID: 30144539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GEPT extract reduces Abeta deposition by regulating the balance between production and degradation of Abeta in APPV717I transgenic mice.
    Tian J; Shi J; Zhang L; Yin J; Hu Q; Xu Y; Sheng S; Wang P; Ren Y; Wang R; Wang Y
    Curr Alzheimer Res; 2009 Apr; 6(2):118-31. PubMed ID: 19355846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of sodium valproate administration on brain neprilysin expression and memory in rats.
    Nalivaeva NN; Belyaev ND; Lewis DI; Pickles AR; Makova NZ; Bagrova DI; Dubrovskaya NM; Plesneva SA; Zhuravin IA; Turner AJ
    J Mol Neurosci; 2012 Mar; 46(3):569-77. PubMed ID: 21932040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.